
Reverb Therapeutics
Reverb Therapeutics is a biotechnology company harnessing the body’s natural immune system and cytokine signalling to treat life-threatening diseases. Its novel antibody-based Amplify•R™ platform amplifies and redirects endogenous cytokines to tissues of interest for the potential treatment of cancer, autoimmune conditions and other diseases.
Established
2023
Aligned investment theme
Elevating inclusive communities
Purpose
To develop precision medicines for life-threatening diseases
InBC commitment amount
$3 million
Year invested
2024